Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Licensing Delineates Helper and Effector NK Cell Subsets During Viral Infection

ABSTRACT: Natural killer (NK) cells can be divided into phenotypic subsets based on the expression of receptors that bind self-MHC-I molecules with differing affinities; a concept termed licensing or education. Here we show that NK cell subsets exhibit markedly different migratory, effector, and immunoregulatory functions on dendritic cells and antigen-specific CD8+ T cell responses during influenza and murine cytomegalovirus infections. Shortly after infection, unlicensed NK cells preferentially trafficked to draining lymph nodes and produced GM-CSF, which promoted the expansion and activation of dendritic cells, and ultimately resulted in sustained antigen-specific CD8+ T cell responses. In contrast, licensed NK cells preferentially migrated to infected parenchymal tissues and produced greater levels of interferon-γ (IFN-γ). Importantly, human NK cell subsets exhibited similar phenotypic characteristics and patterns of cytokine production. Collectively, our studies demonstrate a critical demarcation between the functions of licensed and unlicensed NK cell subsets, with the former functioning as the classical effector subset in inflamed tissues and the latter as modulators of adaptive immunity helping to prime immune responses in draining lymph nodes.

ORGANISM(S): Mus musculus

PROVIDER: GSE72632 | GEO | 2017/08/22

SECONDARY ACCESSION(S): PRJNA294518

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Cytokine and receptor expression in skin draining lymph nodes after skin immunization

Project description:Topical (epicutaneous, e.c.) application of the adjuvant CpG ODN during immunization leads to a robust immune response compared to when subcutaneous (s.c.) administration. Dendritic cells are hematopoietically derived cells that are important in cross-presenting to and activating CD8 T cells. Dermal dendritic cells are one of the two major dendritic cell subsets found in the skin which mobilize from the skin to draining lymph nodes to present to T cells upon activation. Dermal dendritic cells are found in skin draining lymph nodes around 24 hours post immunization. To determine how the immune system respond differently between e.c. versus s.c. administration of CpG ODN, we evaluated changes in the skin draining lymph node environment upon the two routes of adjuvant application. Expression chemokines and chemokine receptors were assessed with real-time qPCR. To determine the changes in the skin draining lymph node environment (cytokine and cytokine receptor levels) upon immunization via real time RT-PCR.

2019-06-28 | GSE133438 | GEO

Inter-myeloid cell synaptic antigen dispersal drives diversified anti-tumor T cell priming

Project description:Using a labelled tumor antigen we identify dendritic cell subsets containing tumor derived antigen in the tumor draining lymph nodes and used these to stimulate anti-tumor OTI CD8 T cells. These were subsequently interrogated by RNAseq to determine how diverse DC subsets drive distinct patterns of CD8 T cell differentiation

2020-11-27 | GSE128980 | GEO

Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles

Project description:Dendritic cell subsets purified from skin-draining lymph nodes of C57BL/6J mice following intradermal injection of non-viable Nippostrongylus brasiliensis (Nb) or topical application of Dibutyl Phthalate-FITC. Results provide insight into the genetic programme induced in DC exposed to Th2 stimuli.

2016-10-20 | GSE88998 | GEO

Immune crosstalk between pancreas, gut and liver through lymph node sharing [bulk RNA-seq]

Project description:To investigate tissue of origin effects on migratory dendritic cell (DC) gene expression in shared lymph nodes we performed bulk RNAseq of DCs from each tissue (liver, pancreas, duodenum). We then performed single cell sequencing of the DCs within the draining lymph nodes.

2022-07-27 | GSE209701 | GEO

Immune crosstalk between pancreas, gut and liver through lymph node sharing [scRNA-seq]

2022-07-27 | GSE209702 | GEO

Lymphoid tissue specific homing of bone marrow-derived dendritic cells

Project description:Because of their potent immunoregulatory capacity, dendritic cells (DCs) have been exploited as therapeutic tools to boost immune responses against tumors or pathogens, or dampen autoimmune or allergic responses. Murine bone marrow-derived DCs (BM-DCs) are the closest known equivalent of the blood monocyte-derived DCs that have been used for human therapy. Current imaging methods have proven unable to properly address the migration of injected DCs to small and deep tissues in mice and humans. This study presents the first extensive analysis of BM-DC homing to lymph nodes (and other selected tissues) after intravenous and intraperitoneal inoculation. Following intravenous delivery, DCs accumulated in the spleen, and preferentially in the pancreatic and lung-draining lymph nodes. In contrast, DCs injected intraperitoneally were found predominantly in peritoneal lymph nodes (pancreatic in particular), and in omentum-associated lymphoid tissue. This uneven distribution of BM-DCs, independent of the mouse strain and also observed within pancreatic lymph nodes, resulted in the uneven induction of an immune response in different lymphoid tissues. These data have important implications for the design of systemic cellular therapy with DCs, and in particular underlie a previously unsuspected potential for specific treatment of diseases such as autoimmune diabetes and pancreatic cancer. This SuperSeries is composed of the following subset Series: GSE15748: Gene expression in PLN vs. ILN or MLN in mice GSE15753: Gene expression in GLN versus PDLN in NOD mice Refer to individual Series

2009-04-23 | E-GEOD-15784 | biostudies-arrayexpress

Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes

Project description:The adaptive limb of the immune system consists of antibody producing B cells and CD4 T helper and CD8 cytotoxic T cells. Besides these classical lymphocyte subsets, unconventional T cells exist that are characterized by a more limited repertoire of their TCR chains. Gamma delta (gd), mucosal-associated invariant (MAIT) and natural killer T cells (NKT) are the major cell types comprising this invariant T cell compartment. These cells are found throughout the body in the non- and lymphoid tissues and they recognize antigens that are linked to non-polymorphic antigen-presenting molecules like CD1 and MR1. Functionally, these cells typically recognize lipids, small-molecule metabolites and phosphoantigens that may be pathogen-derived or expressed by tissues in the context of activation or stress responses. Investigating these cell types on functional level as a group, we found that tissue-derived unconventional T cells constantly migrate like dendritic cells to draining lymph nodes. scRNAseq revealed transcriptional homogeneity of these subsets and shared functional outputs that as group, rather than separate entities, are critical to control bacterial infections. Importantly, since every tissue harbors a unique set of invariant T cells with specific differentiation states (Th1-like, Th2-like and Th17-like) every draining lymph node is as well populated by a unique composition of such cells. By comparing different lymph nodes using scRNA in an unbiased manner, we could resolve internodal differences and further demonstrate the functional consequences on humoral and cellular immune responses. The discovery that every lymph node mounts a unique immune response has a direct impact on vaccination strategies and immunotherapy approaches that aims at harnessing invariant T cells.

2022-08-30 | GSE174629 | GEO

PD-L1 regulates dendritic cell ferroptosis during immunogenic chemotherapy [scRNA-seq]

Project description:Dendritic cells (DCs) express high levels of PD-L1 in the tumor microenvironment and draining lymph nodes. Here, we explore the roles of PD-L1 signaling during immunogenic chemotherapy. DC-conditional PD-L1 knockout mice were inoculated with MC38-OVA tumors and treated with doxorubicin. T cells were isolated from draining lymph node for single cell RNA sequencing.

2024-09-23 | GSE223509 | GEO

Oleuropein reprograms the immunosuppressive footprint of tumor-associated myeloid cells and enhances PD-L1/PD-1 blockade immunotherapy in cancer

Project description:Therapies based on PD-1/PD-L1 blockade fail in most cancer patients. Here we evaluated the capacities of oleuropein to reprogram tumor-associated immunosuppressive myeloid cells to increase the potency of immunotherapies. Oleuropein caused major global reprogramming of monocytic and granulocytic myeloid-derived suppressor cells and tumor-associated macrophages towards immunostimulatory subsets. Differential quantitative proteomics uncovered activated and down-modulated pathways at high resolution for each subset which regulated major differentiation programs. Oleuropein significantly potentiated the capacities of myeloid cells to activate T-cells and enhanced antitumor properties of PD-1 blockade, either by systemic anti-PD-1 antibody administration, or locally by intratumor antibody delivery with a self-amplifying RNA vector based on Semliki Forest virus. Combination therapies decreased tumor infiltration by immunosuppressive myeloid cells and increased dendritic cell recruitment within draining lymph nodes, leading to systemic antitumor T-cell responses. Potent therapeutic activities were evident in lung cancer models resistant to immunotherapies and in colon cancer models.

2024-12-08 | PXD047616 | JPOST Repository

Lymphoid tissue specific homing of bone marrow-derived dendritic cells

2009-04-23 | GSE15784 | GEO